John-Arne Røttingen

Nat Rev Drug Discov. 2020 May;19(5):302-303. doi: 10.1038/d41573-020-00072-6.
No abstract available

Publication types

  • Interview
  • News

MeSH terms

  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects*
  • Betacoronavirus / isolation & purification
  • COVID-19
  • COVID-19 Drug Treatment
  • Clinical Trials as Topic / standards*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / economics
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Humans
  • Interviews as Topic
  • Pandemics / economics
  • Pandemics / prevention & control*
  • Pneumonia, Viral / economics
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology
  • Research Design*
  • SARS-CoV-2

Substances

  • Antiviral Agents